Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 13, Issue 3, Pages 351-360
Publisher
Informa Healthcare
Online
2014-02-18
DOI
10.1517/14740338.2014.888057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Heart Failure Associated with Dopamine Agonists: A Nested Case–Control Study
- (2013) P. H. Hsieh et al. DRUGS & AGING
- The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
- (2013) Alberto Palazzuoli et al. TheScientificWorldJOURNAL
- Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
- (2013) J. Michael Gaziano et al. Journal of the American Heart Association
- The Impact of Rotigotine on Cardiovascular Autonomic Function in Early Parkinsons Disease
- (2012) Camilla Rocchi et al. EUROPEAN NEUROLOGY
- Neuroanatomy of Dopamine: Reward and Addiction
- (2012) Katherine H. Taber et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Pilot Study of Circulating Prolactin Levels and Endothelial Function in Men With Hypertension
- (2011) K. S. Stamatelopoulos et al. AMERICAN JOURNAL OF HYPERTENSION
- The Dopamine Receptors Mediating Inhibition of the Sympathetic Vasopressor Outflow in Pithed Rats: Pharmacological Correlation with the D2-like Type
- (2011) Guadalupe Manrique-Maldonado et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Dopamine and Vascular Dynamics Control: Present Status and Future Perspectives
- (2011) Seyed Khosrow Tayebati et al. CURRENT NEUROVASCULAR RESEARCH
- Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
- (2011) Maurits E. L. Arbouw et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pramipexole for the treatment of early Parkinson’s disease
- (2011) Santiago Perez-Lloret et al. Expert Review of Neurotherapeutics
- Bromocriptine use and myocardial function
- (2011) Louis C.S. Tan et al. MOVEMENT DISORDERS
- Dopamine agonist use and the risk of heart failure
- (2011) Christel Renoux et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease
- (2011) M. Mostafa Mokhles et al. PHARMACOLOGICAL RESEARCH
- Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease
- (2010) Santiago Perez-Lloret et al. CNS DRUGS
- Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
- (2010) J. M. Gaziano et al. DIABETES CARE
- Bromocriptine: old drug, new formulation and new indication
- (2010) R. I. G. Holt et al. DIABETES OBESITY & METABOLISM
- Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance
- (2010) Isabel García-Tornadú et al. ENDOCRINOLOGY
- Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2010) Paolo Barone et al. LANCET NEUROLOGY
- Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
- (2010) Santiago Perez-Lloret et al. MOVEMENT DISORDERS
- Rare and serious cardiac side effects during ropinirole titration
- (2010) Raffaella Di Giacopo et al. MOVEMENT DISORDERS
- New Insights into the Endocrine and Metabolic Roles of Dopamine D2 Receptors Gained from the Drd2–/– Mouse
- (2010) Isabel Garcia-Tornadú et al. NEUROENDOCRINOLOGY
- A reassessment of risks and benefits of dopamine agonists in Parkinson's disease
- (2009) Angelo Antonini et al. LANCET NEUROLOGY
- α2-Adrenoceptor subtypes-mediated physiological, pharmacological actions
- (2009) Klára Gyires et al. NEUROCHEMISTRY INTERNATIONAL
- Ergotamine-derived dopamine agonists and left ventricular function in Parkinson patients: systolic and diastolic function studied by conventional echocardiography, tissue Doppler imaging, and two-dimensional speckle tracking
- (2008) V. G. Rasmussen et al. European Journal of Echocardiography
- Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways
- (2007) Arturo E. Gonzalez-Iglesias et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started